Department of Radiology, Massachusetts General Hospital, 55 Fruit St, White 270, Boston, MA 02114, USA.
J Vasc Interv Radiol. 2010 Aug;21(8 Suppl):S214-22. doi: 10.1016/j.jvir.2010.01.046.
Local ablative therapy for the treatment of metastatic disease to the liver has been evaluated most extensively in colorectal cancer with 5-year survival rates up to 55% after RF ablation. Recent findings suggest selected patients with other malignant processes may benefit as well, but conclusive evidence is limited. This article reviews the available literature regarding the use of radiofrequency ablation, microwave ablation, and cryoablation in the treatment of metastatic disease to the liver. The published results of each of these modalities in the treatment of metastatic disease to the liver are promising, and outcomes continue to be evaluated.
局部消融治疗在转移性肝癌的治疗中得到了最广泛的评估，在结直肠癌中，射频消融后的 5 年生存率高达 55%。最近的研究结果表明，其他恶性肿瘤的一些特定患者也可能从中受益，但确凿的证据有限。本文回顾了射频消融、微波消融和冷冻消融在治疗转移性肝癌中的应用相关文献。这些方法在治疗转移性肝癌中的应用结果都很有前景，其疗效也在持续评估中。
